14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 DXCM stock ended at $130.10. This is 0.347% more than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 1.00% from a day low at $129.04 to a day high of $130.32.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical DexCom prices

Date Open High Low Close Volume
Mar 03, 2021 $386.79 $386.79 $364.60 $368.70 1 307 234
Mar 02, 2021 $396.00 $398.46 $387.16 $391.91 641 133
Mar 01, 2021 $400.40 $401.99 $392.99 $396.67 715 671
Feb 26, 2021 $396.79 $402.49 $386.12 $397.78 666 701
Feb 25, 2021 $405.64 $405.82 $390.67 $395.47 621 710
Feb 24, 2021 $403.18 $407.33 $399.73 $405.64 583 457
Feb 23, 2021 $406.98 $411.73 $396.49 $406.78 772 759
Feb 22, 2021 $416.75 $422.26 $408.80 $412.06 640 570
Feb 19, 2021 $411.86 $423.40 $406.54 $418.94 947 659
Feb 18, 2021 $412.42 $413.42 $402.64 $410.84 603 538
Feb 17, 2021 $406.28 $417.29 $400.19 $414.12 651 661
Feb 16, 2021 $411.00 $412.60 $400.31 $404.38 877 280
Feb 12, 2021 $387.98 $414.34 $381.05 $412.56 1 925 259
Feb 11, 2021 $404.62 $411.06 $399.15 $410.20 665 230
Feb 10, 2021 $406.43 $406.43 $396.18 $399.44 695 310
Feb 09, 2021 $405.75 $408.00 $397.81 $401.03 765 929
Feb 08, 2021 $414.78 $415.00 $402.62 $403.30 868 478
Feb 05, 2021 $408.02 $412.24 $404.00 $411.03 558 587
Feb 04, 2021 $395.48 $408.10 $392.84 $403.25 788 446
Feb 03, 2021 $392.47 $395.00 $383.06 $391.69 737 526
Feb 02, 2021 $387.23 $401.65 $385.20 $394.63 863 474
Feb 01, 2021 $376.35 $386.59 $373.00 $382.62 722 537
Jan 29, 2021 $362.57 $379.06 $359.80 $374.85 1 083 277
Jan 28, 2021 $353.29 $368.97 $350.50 $366.89 924 440
Jan 27, 2021 $359.70 $361.21 $349.00 $349.64 1 033 458
Click to get the best stock tips daily for free!

About DexCom

DexCom DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to i... DXCM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT